Cipla has target of Rs 320: Mohindar

Rahul Mohindar of Viratechindia is of the view that health care is looking good on the whole that is the sector I would like to be in. Cipla has target of Rs 320.

Mohindar told CNBC-TV18, “I think health care is looking good on the whole, that is the sector I would like to be in. Even sugar which has taken a slight dip today could be looked into as an opportunity to buy. Stock specifically I would like to stick to frontline health care. Cipla we have a target of Rs 320, Ranbaxy Laboratories could move to levels like Rs 440, Bajaj Hindusthan is something which could move to Rs 238. So these are the ideas I would like to trade in the immediate short-term.”